Skip to main content
Pharmaids Pharmaceuticals Ltd. logo

Pharmaids Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · 524572 ISIN · INE117D01018 LEI · 64881R93DKT67Q1W7C21 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS 524572

About Pharmaids Pharmaceuticals Ltd.

https://www.pharmaids.com

Pharmaids Pharmaceuticals Ltd. specializes in the formulation, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its core portfolio encompasses various delivery systems, including solid orals like tablets and capsules, as well as liquid preparations, topical ointments, and injectables. The company addresses diverse therapeutic categories such as anti-infectives, analgesics, gastrointestinal health, and nutritional support. Committed to stringent quality assurance and research-led development, the organization focuses on delivering standardized medicinal solutions. Its operational framework prioritizes regulatory compliance and the optimization of manufacturing processes to support healthcare delivery across multiple clinical segments.

Recent filings

Filing Released Lang Actions
Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Regulatory Filings Classification · 85% confidence The document is a notice under SEBI Listing Regulations to BSE about an upcoming Board of Directors meeting to approve audited financial results and related trading window closure. It is a routine regulatory announcement rather than the report itself or a management change filing. It does not present financial results, management changes, or constitute a proxy or dividend notice. Therefore, it falls under General Regulatory Filings (RNS).
2026-05-22 English
Pursuant to the Regulation 24A of SEBI (LODR) Regulations, 2015, enclosed is the Annual Secretarial Compliance Report for the year ended March 31, 2026.
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report' for the financial year ended March 31, 2026, issued by a Practicing Company Secretary. It is addressed to the stock exchange and certifies compliance with SEBI regulations and listing obligations. The content includes compliance status, observations, and management responses related to secretarial standards and regulatory adherence. It does not contain financial statements or detailed financial performance data. The document is a compliance certification report rather than a full annual report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications and compliance reports that do not contain substantive financial data.
2026-05-08 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.